Assignee profile:

ONCOTHYREON INC.

City:

Seattle, Washington

Country:

United States

Published Applications:

14

Last publication date:

2015-03-12

Patent Grants:

10

Last grant date:

2015-09-01

Top Inventors for applications by ONCOTHYREON INC.

These are the the leading inventors for applications assigned to ONCOTHYREON INC.:

Recent patent applications by ONCOTHYREON INC.

ONCOTHYREON INC. based in Seattle, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2015-03-12 ✅ Patent 9,119,784 granted on 2015-09-01
US20150071990A1
Human necessities

Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine

#2 | 2014-09-18
US20140275234A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS OF USING CRYSTALLINE FORMS OF WORTMANNIN ANALOGS

#3 | 2013-05-23
US20130131156A1
Chemistry; metallurgy

Cancer Treatment with Wortmannin Analogs

#4 | 2013-05-23
US20130129720A1
Human necessities

Combination Cancer Therapies with Wortmannin Analogs

#5 | 2012-11-08 ✅ Patent 8,329,639 granted on 2012-12-11
US20120282329A1
Human necessities

MUC1 based glycolipopeptide vaccine with adjuvant

#6 | 2012-10-25 ✅ Patent 8,552,145 granted on 2013-10-08
US20120269884A1
Chemistry; metallurgy

Vaccine for modulating between T1 and T2 immune responses

#7 | 2012-08-30 ✅ Patent 8,889,616 granted on 2014-11-18
US20120219617A1
Human necessities

MUC1 based glycolipopeptide vaccine with adjuvant

#8 | 2012-06-12 ✅ Patent 8,198,400 granted on 2012-06-12
US10106876
-

Vaccine for modulating between T1 and T2 immune responses

#9 | 2012-02-09
US20120034294A1
Chemistry; metallurgy

METHOD OF MAKING SMALL LIPOSOMES

#10 | 2012-01-05 ✅ Patent 8,097,593 granted on 2012-01-17
US20120003295A1
Chemistry; metallurgy

Lipid A and other carbohydrate ligand analogs

#11 | 2008-06-05 ✅ Patent 9,173,929 granted on 2015-11-03
US20080131495A1
Human necessities

Mucinous glycoprotein (MUC-1) vaccine

#12 | 2007-01-18 ✅ Patent 8,871,250 granted on 2014-10-28
US20070014844A1
Human necessities

Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine

#13 | 2006-08-24 ✅ Patent 7,741,297 granted on 2010-06-22
US20060189550A1
Chemistry; metallurgy

Immunostimulatory, covalently lipidated oligonucleotides

#14 | 2006-02-23 ✅ Patent 7,820,627 granted on 2010-10-26
US20060040891A1
Chemistry; metallurgy

Lipid A and other carbohydrate ligand analogs

Also check out Oncothyreon Inc.'s (Seattle, United States) applicant profile with 1 patent applications submitted.

AssigneeID:

23971 ⎘